-
IBI318 Plus Lenvatinib Tackles Resistant Lung Cancer
16 Dec 2025 06:48 GMT
… non-small cell lung cancer (NSCLC) who … -small cell lung cancer treatment resistant to immune … -small cell lung canceranti-tumor immunity strategiescancer … resistanceinnovative cancer therapeuticslenvatinib lung cancer treatmentovercoming immune resistancePhase …
-
Korean team identifies ‘resistance switch’ in KRAS-mutated lung cancer
16 Dec 2025 06:48 GMT
… drive drug resistance in lung cancer.
Professor Shin Dong-hoon … of anticancer drugs in lung cancers harboring KRAS mutations. The … develops in KRAS-mutated lung cancer.
KRAS mutations are … by acquired resistance and treatment-related toxicity.
Rather than …
-
Cough, weight loss, breathlessness: Non-smoking women drive lung cancer spike in India's metro cities; early diagnosis urged
16 Dec 2025 09:01 GMT
Lung cancer is increasingly affecting non-smoking … initiatives for improved screening and treatment.
-
Ewha hospital reports faster recovery with ERAS lung cancer surgery
16 Dec 2025 02:58 GMT
… entirely under sedation without intubation.
Lung cancer surgery is generally categorized as … potentially improve long-term survival.
“Lung cancer can be effectively treated when … , patients can improve not only treatment outcomes but also their overall …
-
<![CDATA[Facing Lung Cancer Together: A Patient and Care Partner Share Their Journey ]]>
15 Dec 2025 23:55 GMT
… lung cancer patients, which then gave me more information as to different treatments … for research, because lung cancer receives the least … Even there are more lung cancer deaths worldwide than breast … of cancer, but especially lung cancer. Screen, catch it …
-
UK researchers partner with Kentucky communities to reduce lung cancer stigma, promote screening
15 Dec 2025 21:31 GMT
… , 2025) — During National Lung Cancer Screening Awareness Month, University of … work to expand lung-cancer screening outreach and education … ’m proof that treatment works and there is … Department for Public Health Lung Cancer Screening Program, the …
-
ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab approved in the US as first new treatment in a decade for the 1st-line treatment of patients with HER2-positive metastatic breast cancer
16 Dec 2025 03:09 GMT
… Cell Lung Cancer (NSCLC)
- As monotherapy for the treatment of … was stratified by prior treatment ( de novo metastatic … A report from the Lung Cancer Mutation Consortium. Cancer. 2017 … Breast Cancer: Patient Characteristics, Treatment, and Survival from the …
-
<![CDATA[CNS Disease Considerations and Implications for Treatment Selection for BRAF V600E-Mutant Metastatic NSCLC ]]>
16 Dec 2025 01:40 GMT
This segment addresses one of the most challenging areas of lung cancer management: patients with baseline brain metastases. Because BRAF-mutant lung cancer is not particularly CNS-tropic, the incidence of brain metastases is lower than in EGFR- or ALK- …
-
New EGFR Lung Cancer Drug Nears EU Approval
15 Dec 2025 16:25 GMT
… advanced non–small-cell lung cancer (NSCLC).
The recommendation … EGFR)‑mutant disease and treatment of patients with acquired … (L858R) substitution mutations.
Treatment of adult patients with … information once published. Treatment should be initiated by …
-
RWJUH, RCI debut Ion robotic bronchoscopy for lung cancer
15 Dec 2025 13:05 GMT
… and more precise diagnosis of lung cancer by interventional pulmonologists and … advanced therapies, and cutting-edge treatments.”
In addition to these offerings … promote early detection of lung cancer through its Lung Cancer Screening Program. More details …
About
© 1995-2025